Concord Drugs Ltd Share Price

Q: What is the share price of Concord Drugs Ltd today?

Concord Drugs Ltd share price as on 3 Jan 2025 is ₹38.31

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

BSE: 538965 Small Cap ISIN: INE858L01010

As on 03 January 2025 at 06:26 IST

₹38.31

+ 0.35

(0.92%)

Buy Sell

Over 1 Month

9.46%

Over 6 Months

-0.88%

Over 1 Year

-28.86%

Over 3 Years

13.51%

Overview News Financials Corporate Actions

Concord Drugs Ltd Summary

Close 38.31

Open 37.96

High 41

Low 37.95

Volume 19,577

Net Turnover (in ₹) 7,63,454

52 Week High 54.90

52 Week Low 30.59

52Wk High / Low

30.59

54.90

Concord Drugs Ltd Key Financial Data

Market Cap (in ₹ Cr) 38.31

EPS (TTM) -

Book Value (BV) 33.88

Div. Yield -

P/E (TTM) -72.28

Price/Book Value 1.13

Delivery % 59.47

Face Value 10

Concord Drugs Ltd Key Ratios

P/E ratio 83.74

P/B ratio 1.04

EV to Sales 1.15

PEG Ratio -1.49

ROA 0.82

ROE 1.28

Debt-Equity 0.47

Net Profit Margin 0.97

Operating Profit Margin 8.53

Concord Drugs Ltd Peer Comparison

Company	LTP	Market Cap (in ₹ Cr)
Concord Drugs Ltd	₹38.31	₹38.31
Sun Pharmaceuticals Industries Ltd	₹1,878	₹4,50,595.11
Divis Laboratories Ltd	₹6,143.45	₹1,63,089.29
Cipla Ltd	₹1,537.55	₹1,24,174.70
Mankind Pharma Ltd	₹2,899.55	₹1,19,625.84
Torrent Pharmaceuticals Ltd	₹3,446.25	₹1,16,631.52

Concord Drugs Ltd News

Concord Drugs announces board meeting date

On 13 November 2024

08 Nov 2024

Concord Drugs to conduct AGM

On 30 September 2024

19 Sep 2024

Concord Drugs schedules AGM

On 30 September 2024

19 Sep 2024

Concord Drugs fixes board meeting date

On 6 September 2024

03 Sep 2024

Concord Drugs to table results

On 9 August 2024

06 Aug 2024

Concord Drugs Ltd Financials

Standalone

Consolidated

Profit and Loss

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	43.27	51.32	59.06	51.45	51.46
Total Expenses	42.71	50.20	56.81	50.92	51
Profit Before Tax	0.56	1.13	2.25	4.29	0.46
Profit After Tax	0.42	0.89	1.59	3.28	0.33
Operating Profit after Depreciation	2.15	2.75	3.93	1.95	2

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	10.99	12.22	13.33	13.19	9.74
Total Non Current Assets	14.92	15.23	14.55	13.86	12.45
Total Current Assets	41.38	41.40	41.89	36.03	45.56
TOTAL ASSETS	56.30	56.63	56.45	49.88	58.02
Total Shareholder's Fund	33.82	31.70	28.36	26.77	23.48

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	1.96	2.24	0.77	1.62	2.48
Net Cash used in Investing Activities	-1.21	-2.27	-2.44	-3.67	-0.84
Net Cash used in Financing Activities	-0.69	0.05	1.68	2.07	-1.79

Profit and Loss

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	44.93	52.09	59.06	-	-
Total Expenses	44.30	50.84	56.81	-	-
Profit Before Tax	0.63	1.25	2.25	-	-
Profit After Tax	0.47	0.99	1.59	-	-
Operating Profit after Depreciation	2.50	2.96	3.93	-	-

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	11.04	12.28	13.33	-	-
Total Non Current Assets	14.19	14.77	14.55	-	-
Total Current Assets	44.62	43.46	41.89	-	-
TOTAL ASSETS	58.81	58.23	56.45	-	-
Total Shareholder's Fund	33.82	31.70	28.36	-	-

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	0.79	1.66	0.77	-	-
Net Cash used in Investing Activities	-1.01	-2.27	-2.44	-	-
Net Cash used in Financing Activities	0.28	0.62	1.68	-	-

Concord Drugs Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

Concord Drugs Ltd Stock Analysis

Annual revenue for Concord Drugs Ltd decreased by 15.69% to ₹43.27 crore in FY 2024 from ₹51.32 crore in FY 2023.
Annual Net Profit for Concord Drugs Ltd decreased by 52.99% to ₹0.42 crore in FY 2024 from ₹0.89 crore in FY 2023.
Promoter Shareholding in Concord Drugs Ltd decreased by 1.83% in the most recent quarter, from 55.41% in June 2024 to 54.39% in September 2024.
Concord Drugs Ltd delivered a 1-year return of -28.86% compared to the Nifty 50, which provided a return of 0% as of the last trading session.
Concord Drugs Ltd share price moved up by 0.92% from its previous close of INR ₹37.96. The latest Concord Drugs Ltd share price is INR ₹38.31.
Concord Drugs Ltd share price today has been at a low of 37.95 and a high of 41. Over the past 52 weeks, the Concord Drugs Ltd share price has seen a low of 30.59 and a high of 54.90.

FAQ’s

What is the share price of Concord Drugs Ltd today?

Concord Drugs Ltd share price as on 3 Jan 2025 is ₹ 38.31

What is the Market Cap of Concord Drugs Ltd?

The market cap of Concord Drugs Ltd stock is ₹38.31 Cr.

What is the PE Ratio of Concord Drugs Ltd?

The Price to Earnings (P/E) Ratio of Concord Drugs Ltd is 83.74

What is the PB Ratio of Concord Drugs Ltd?

The Price to Book (P/B) Ratio of Concord Drugs Ltd is 1.04

What is the 52 week high of Concord Drugs Ltd Share Price?

The 52 week high of Concord Drugs Ltd share price stands at ₹57.88

What is the 52 week low of Concord Drugs Ltd Share Price?

The 52 week low of Concord Drugs Ltd share price stands at ₹30.59

Open Free
Demat Account!

Enjoy ₹11 Brokerage on Stocks Delivery

Equity, F&O and
DP Charges